生命科学资讯

Apple Tree Partners scores legal win against alleged holdout Russian investor

ACIP vote, more FDA turnover; Introducing Endpoints Signal; ARCH, Parker Institute building next cancer bet; and more

How is Agilent Technologies' stock performance compared to other healthcare stocks? - MSN

Epoch Investment Partners Inc. Sells 53,867 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

First Trust Advisors LP Sells 22,018 Shares of Waters Corporation $WAT - MarketBeat

Agilent Technologies (A) Price Target Increased by 10.53% to 170.51 - Nasdaq

Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo Finance

Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo! Finance Canada

ORIC’s lung cancer pill shows promise in some settings but is dropped for HER2 mutations

Illumina (ILMN): Reassessing Valuation After Recent Share Price Momentum From a Low Base - simplywall.st

‘Market’s thinking is backwards’: FDA’s 1-trial approval plan would boost R&D spend, Jefferies says

FDA panel votes against J&J's novel shunt implant for heart failure

Michel Lagarde Sells 32,000 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat

RFK Jr.’s hand-picked panel questions childhood vaccine schedule

Lagarde of Thermo Fisher sells $12.4m in stock - Investing.com

Will Thermo Fisher's Asia Bioprocessing Tri-Hub Expansion Reshape Thermo Fisher Scientific's (TMO) Narrative? - simplywall.st

Natera buys Foresight Diagnostics in cancer testing deal worth up to $450M

Encoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data

'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out

How AI and real-world evidence are powering smarter decisions across the drug and device development lifecycle